These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37338608)

  • 21. Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study.
    Lappe J; Kunz I; Bendik I; Prudence K; Weber P; Recker R; Heaney RP
    Eur J Nutr; 2013 Feb; 52(1):203-215. PubMed ID: 22302614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis.
    Beck TJ; Fuerst T; Gaither KW; Sutradhar S; Levine AB; Hines T; Yu CR; Williams R; Mirkin S; Chines AA
    Bone; 2015 Aug; 77():115-9. PubMed ID: 25917574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.
    Storm D; Eslin R; Porter ES; Musgrave K; Vereault D; Patton C; Kessenich C; Mohan S; Chen T; Holick MF; Rosen CJ
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3817-25. PubMed ID: 9814452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
    Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
    Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postmenopausal osteoporosis. Role of vitamin K in the prevention of osteoporosis].
    Malinova M
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():43-8. PubMed ID: 24294745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial.
    Levy-Schousboe K; Marckmann P; Frimodt-Møller M; Peters CD; Kjærgaard KD; Jensen JD; Strandhave C; Sandstrøm H; Hitz MF; Langdahl B; Vestergaard P; Brasen CL; Schmedes A; Madsen JS; Jørgensen NR; Frøkjær JB; Frandsen NE; Petersen I; Hansen D
    Nephrol Dial Transplant; 2023 Sep; 38(10):2131-2142. PubMed ID: 36460034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive effects of a chicken eggshell powder-enriched vitamin-mineral supplement on femoral neck bone mineral density in healthy late post-menopausal Dutch women.
    Schaafsma A; van Doormaal JJ; Muskiet FA; Hofstede GJ; Pakan I; van der Veer E
    Br J Nutr; 2002 Mar; 87(3):267-75. PubMed ID: 12064336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis: trials and tribulations.
    Seeman E
    Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Liu C; Kuang X; Li K; Guo X; Deng Q; Li D
    Food Funct; 2020 Dec; 11(12):10817-10827. PubMed ID: 33237064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women.
    Bolton-Smith C; McMurdo ME; Paterson CR; Mole PA; Harvey JM; Fenton ST; Prynne CJ; Mishra GD; Shearer MJ
    J Bone Miner Res; 2007 Apr; 22(4):509-19. PubMed ID: 17243866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nutritional intervention upon bone turnover in elderly hip fracture patients. Randomized controlled trial.
    Torbergsen AC; Watne LO; Frihagen F; Wyller TB; Mowè M
    Clin Nutr ESPEN; 2019 Feb; 29():52-58. PubMed ID: 30661701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12-month randomized controlled study.
    Flodin L; Sääf M; Cederholm T; Al-Ani AN; Ackermann PW; Samnegård E; Dalen N; Hedström M
    Clin Interv Aging; 2014; 9():1043-50. PubMed ID: 25045257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression.
    Rabenda V; Bruyère O; Reginster JY
    Osteoporos Int; 2011 Mar; 22(3):893-901. PubMed ID: 21060990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
    Avenell A; Gillespie WJ; Gillespie LD; O'Connell D
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000227. PubMed ID: 19370554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China.
    Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
    Medicine (Baltimore); 2018 Aug; 97(31):e11694. PubMed ID: 30075569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
    Henriksen K; Byrjalsen I; Andersen JR; Bihlet AR; Russo LA; Alexandersen P; Valter I; Qvist P; Lau E; Riis BJ; Christiansen C; Karsdal MA;
    Bone; 2016 Oct; 91():122-9. PubMed ID: 27462009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.
    Binkley N; Harke J; Krueger D; Engelke J; Vallarta-Ast N; Gemar D; Checovich M; Chappell R; Suttie J
    J Bone Miner Res; 2009 Jun; 24(6):983-91. PubMed ID: 19113922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of calcium, vitamins K1 and D3 on bone in galactosemia.
    Panis B; Vermeer C; van Kroonenburgh MJPG; Nieman FHM; Menheere PPCA; Spaapen LJ; Rubio-Gozalbo ME
    Bone; 2006 Nov; 39(5):1123-1129. PubMed ID: 16782422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.